IRCCS di Reggio Emilia Institute
A randomized multicenter study to evaluate the efficacy of early administration of Tocilizumab (TCZ) in patients with COVID-19 pneumonia.
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
Italy
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership